Normal pressure hydrocephalus (NPH) is potentially treatable form of dementia, which along with gait disturbance and impaired urinary control compose a clinical picture of the Hakim-Adams syndrome. In advanced age it could be challenging to distinguish the disease from other form of dementias or brain atrophy. From another prospective, other brain conditions could have a number of similar symptoms that could make it even harder to raise a suspicion of NPH. In this article we describe a clinical picture, neurological examination data, neuroimaging and clinical analysis of blood and cerebrospinal fluid (CSF) of the patient with confirmed multiple sclerosis (MS) and symptoms falling under Hakim-Adams triad criteria. On the other hand, pronounced cortical atrophy and patient`s cognitive decline, could be a consequence of prolonged disease, absence of disease-modifying treatment and poor compliance of the patient. Challenges in management of the patient were not only limited by the duration of the multiple sclerosis, but also a number of comorbidities in the history of the disease and not straightforward data after performing the tap test. Thorough review of a patient with multiple sclerosis with clinical manifestations corresponding to Hakim's triad, and with ventriculomegaly on CT/MRI, should be performed as the comorbidity of MS and NPH has to be excluded.
Published in | American Journal of Psychiatry and Neuroscience (Volume 11, Issue 2) |
DOI | 10.11648/j.ajpn.20231102.11 |
Page(s) | 34-40 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Normal Pressure Hydrocephalus, Multiple Sclerosis, Dementia, Ventricular Shunt
[1] | Goldenberg MM (2012). Multiple sclerosis review. P & T: a peer-reviewed journal for formulary management, 37 (3), 175–184. |
[2] | Clinical significance of cerebrospinal fluid tap test and magnetic resonance imaging/computed tomography findings of tight high convexity in patients with possible idiopathic normal pressure hydrocephalus. Ishikawa M, Oowaki H, Matsumoto A, Suzuki T, Furuse M, Nishida N Neurol Med Chir (Tokyo). 2010; 50 (2): 119-23; discussion 123. |
[3] | Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus PMCID: PMC7905302 PMID: 33455998. |
[4] | The clinical effect of lumbar puncture in normal pressure hydrocephalus. Wikkelsø C, Andersson H, Blomstrand C, Lindqvist GJ Neurol Neurosurg Psychiatry. 1982 January; 45 (1): 64-9. |
[5] | CSF tap test - Obsolete or appropriate test for predicting shunt responsiveness? A systemic review. Mihalj MJ Neurol Sci. 2016 Nov 15; 370 (): 157. |
[6] | A systematic review of the diagnostic utility of simple tests of change after trial removal of cerebrospinal fluid in adults with normal pressure hydrocephalus. Scully AE, Lim ECW, Teow PP, Tan DML Clin Rehabil. 2018 July; 32 (7): 942-953. |
[7] | Early and delayed assessments of quantitative gait measures to improve the tap test as a predictor of shunt effectiveness in idiopathic normal pressure hydrocephalus. Ishikawa M, Yamada S, Yamamoto K Fluid Barriers CNS. 2016 Nov 22; 13 (1): 20. |
[8] | Objective assessment of gait in normal-pressure hydrocephalus. Williams MA, Thomas G, de Lateur B, Imteyaz H, Rose JG, Shore WS, Kharkar S, Rigamonti D Am J Phys Med Rehabil. 2008 January; 87 (1): 39-45. |
[9] | Idiopathic normal pressure hydrocephalus: diagnostic and predictive value of clinical testing, lumbar drainage, and CSF dynamics. Mahr CV, Dengl M, Nestler U, Reiss-Zimmermann M, Eichner G, Preuß M, Meixensberger J J Neurosurg. 2016 Sep; 125 (3): 591-7. |
[10] | Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients. Marmarou A, Young HF, Aygok GA, Sawauchi S, Tsuji O, Yamamoto T, Dunbar J J Neurosurg. 2005 June; 102 (6): 987-97. |
[11] | Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomized trial. Kazui H, Miyajima M, Mori E, Ishikawa M, SINPHONI-2 Investigators. Lancet Neurol. 2015 June; 14 (6): 585-94. |
[12] | Kubo Y, Kazui H, Yoshida T, Kito Y, Kimura N, Tokunaga H, Ogino A, Miyake H, Ishikawa M, Takeda M. Validation of grading scale for evaluating symptoms of idiopathic normal-pressure hydrocephalus. Dement Geriatr Cogn Disord. 2008; 25 (1): 37-45. doi: 10.1159/000111149. Epub 2007 Nov 20. PMID: 18025828. |
[13] | Immunology of multiple sclerosis. Mireia Sospedra and Roland Martin Annual Review of Immunology 2005 23: 1, 683-747. |
[14] | Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Multiple sclerosis—candidate mechanisms underlying CNS atrophy. Trends Neurosci. 2010; 33: 202–10. |
[15] | Nancy D Chiaravalloti, John DeLuca, Cognitive impairment in multiple sclerosis, The Lancet Neurology, Volume 7, Issue 12, 2008, Pages 1139-1151, ISSN 1474-4422. |
[16] | The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. Walchenbach R, Geiger E, Thomeer RT, Vanneste JA J Neurol Neurosurg Psychiatry. 2002 April; 72 (4): 503-6. |
[17] | Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. Tullberg M, Jensen C, Ekholm S, Wikkelsø C AJNR Am J Neuroradiol. 2001 October; 22 (9): 1665-73. |
[18] | The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. Wikkelsø C, Hellström P, Klinge PM, Tans JT, European iNPH Multicentre Study Group. J Neurol Neurosurg Psychiatry. 2013 May; 84 (5): 562-8. |
[19] | Normal-pressure hydrocephalus: white matter lesions correlate negatively with gait improvement after lumbar puncture Paulo Bugalho 1, Luísa Alves Affiliations expand PMID: 17768003 DOI: 10.1016/j.clineuro.2007.07.012. |
[20] | Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions. Krauss JK, Droste DW, Vach W, Regel JP, Orszagh M, Borremans JJ, Tietz A, Seeger W Neurosurgery. 1996 August; 39 (2): 292-9; discussion 299-300. |
[21] | Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus. Hiraoka K, Narita W, Kikuchi H, Baba T, Kanno S, Iizuka O, Tashiro M, Furumoto S, Okamura N, Furukawa K, Arai H, Iwata R, Mori E, Yanai KJ Neurol Sci. 2015 Sep 15; 356 (1-2): 124-8. |
[22] | Sastre-Garriga J, Ingle GT, Chard DT, Cercignani M, Ramió -Torrentà L, Miller DH, Thompson AJ. Gray and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage. 2004; 22: 353–9. |
[23] | Cognitive presentation of multiple sclerosis: evidence for a cortical variant. M Zarei, S Chandran, A Compston, J Hodges. |
[24] | Unusual Patient with Multiple Sclerosis and Shunt-Responsive Normal-Pressure Hydrocephalus Article in Clinical Neuroradiology April 2011 DOI: 10.1007/s00062-011-0068-3 Source: PubMed doi: 10.2176/nmc.st.2020-0292. Epub 2021 Jan 15. |
[25] | Apparent hydrocephalus and chronic multiple sclerosis: a report of two cases. O'Brien T, Paine M, Matotek K, Byrne E, Author information Clinical and Experimental Neurology, 01 Jan 1993, 30: 137-143 PMID: 7712624. |
[26] | Early evaluation of cerebral metabolic rate of glucose (CMRglu) with 18F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement: preliminary experience. Calcagni ML, Lavalle M, Mangiola A, Indovina L, Leccisotti L, De Bonis P, Marra C, Pelliccioni A, Anile C, Giordano A Eur J Nucl Med Mol Imaging. 2012 February; 39 (2): 236-41. |
[27] | F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus. Townley RA, Botha H, Graff-Radford J, Boeve BF, Petersen RC, Senjem ML, Knopman DS, Lowe V, Jack CR Jr, Jones DT Neuroimage Clin. 2018; 18: 897-902. |
[28] | Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Jeppsson A, Zetterberg H, Blennow K, Wikkelsø C Neurology. 2013 Apr 9; 80 (15): 1385-92. |
APA Style
Solomiia Bandrivska, Mykhailo Bandrivskyi, Iryna Pepenina, Natalia Maslianchuk, Natalia Mykhailovska, et al. (2023). Clinical and Radiological Features of Possible Normal Pressure Hydrocephalus in a Patient with Multiple Sclerosis. American Journal of Psychiatry and Neuroscience, 11(2), 34-40. https://doi.org/10.11648/j.ajpn.20231102.11
ACS Style
Solomiia Bandrivska; Mykhailo Bandrivskyi; Iryna Pepenina; Natalia Maslianchuk; Natalia Mykhailovska, et al. Clinical and Radiological Features of Possible Normal Pressure Hydrocephalus in a Patient with Multiple Sclerosis. Am. J. Psychiatry Neurosci. 2023, 11(2), 34-40. doi: 10.11648/j.ajpn.20231102.11
AMA Style
Solomiia Bandrivska, Mykhailo Bandrivskyi, Iryna Pepenina, Natalia Maslianchuk, Natalia Mykhailovska, et al. Clinical and Radiological Features of Possible Normal Pressure Hydrocephalus in a Patient with Multiple Sclerosis. Am J Psychiatry Neurosci. 2023;11(2):34-40. doi: 10.11648/j.ajpn.20231102.11
@article{10.11648/j.ajpn.20231102.11, author = {Solomiia Bandrivska and Mykhailo Bandrivskyi and Iryna Pepenina and Natalia Maslianchuk and Natalia Mykhailovska and Iryna Lasiichuk and Viktoriia Gryb and Tatyana Slobodin}, title = {Clinical and Radiological Features of Possible Normal Pressure Hydrocephalus in a Patient with Multiple Sclerosis}, journal = {American Journal of Psychiatry and Neuroscience}, volume = {11}, number = {2}, pages = {34-40}, doi = {10.11648/j.ajpn.20231102.11}, url = {https://doi.org/10.11648/j.ajpn.20231102.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20231102.11}, abstract = {Normal pressure hydrocephalus (NPH) is potentially treatable form of dementia, which along with gait disturbance and impaired urinary control compose a clinical picture of the Hakim-Adams syndrome. In advanced age it could be challenging to distinguish the disease from other form of dementias or brain atrophy. From another prospective, other brain conditions could have a number of similar symptoms that could make it even harder to raise a suspicion of NPH. In this article we describe a clinical picture, neurological examination data, neuroimaging and clinical analysis of blood and cerebrospinal fluid (CSF) of the patient with confirmed multiple sclerosis (MS) and symptoms falling under Hakim-Adams triad criteria. On the other hand, pronounced cortical atrophy and patient`s cognitive decline, could be a consequence of prolonged disease, absence of disease-modifying treatment and poor compliance of the patient. Challenges in management of the patient were not only limited by the duration of the multiple sclerosis, but also a number of comorbidities in the history of the disease and not straightforward data after performing the tap test. Thorough review of a patient with multiple sclerosis with clinical manifestations corresponding to Hakim's triad, and with ventriculomegaly on CT/MRI, should be performed as the comorbidity of MS and NPH has to be excluded.}, year = {2023} }
TY - JOUR T1 - Clinical and Radiological Features of Possible Normal Pressure Hydrocephalus in a Patient with Multiple Sclerosis AU - Solomiia Bandrivska AU - Mykhailo Bandrivskyi AU - Iryna Pepenina AU - Natalia Maslianchuk AU - Natalia Mykhailovska AU - Iryna Lasiichuk AU - Viktoriia Gryb AU - Tatyana Slobodin Y1 - 2023/04/11 PY - 2023 N1 - https://doi.org/10.11648/j.ajpn.20231102.11 DO - 10.11648/j.ajpn.20231102.11 T2 - American Journal of Psychiatry and Neuroscience JF - American Journal of Psychiatry and Neuroscience JO - American Journal of Psychiatry and Neuroscience SP - 34 EP - 40 PB - Science Publishing Group SN - 2330-426X UR - https://doi.org/10.11648/j.ajpn.20231102.11 AB - Normal pressure hydrocephalus (NPH) is potentially treatable form of dementia, which along with gait disturbance and impaired urinary control compose a clinical picture of the Hakim-Adams syndrome. In advanced age it could be challenging to distinguish the disease from other form of dementias or brain atrophy. From another prospective, other brain conditions could have a number of similar symptoms that could make it even harder to raise a suspicion of NPH. In this article we describe a clinical picture, neurological examination data, neuroimaging and clinical analysis of blood and cerebrospinal fluid (CSF) of the patient with confirmed multiple sclerosis (MS) and symptoms falling under Hakim-Adams triad criteria. On the other hand, pronounced cortical atrophy and patient`s cognitive decline, could be a consequence of prolonged disease, absence of disease-modifying treatment and poor compliance of the patient. Challenges in management of the patient were not only limited by the duration of the multiple sclerosis, but also a number of comorbidities in the history of the disease and not straightforward data after performing the tap test. Thorough review of a patient with multiple sclerosis with clinical manifestations corresponding to Hakim's triad, and with ventriculomegaly on CT/MRI, should be performed as the comorbidity of MS and NPH has to be excluded. VL - 11 IS - 2 ER -